Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This disease is characterized by progressive cerebellar ataxia with pyramidal and spinal cord dysfunction, associated with distinctive MRI anomalies and increased lactate in the abnormal white matter.
Features include very common findings: Abnormal spinal cord dorsal column morphology; and common findings: Abnormal cerebellum morphology, Progressive cerebellar ataxia, Abnormal speech pattern, and Progressive spasticity and others. 57 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 29 | Hyporeflexia, Peripheral axonal neuropathy, Babinski sign |
Muscles | 12 | Skeletal muscle atrophy, Flexion contracture, Muscle weakness |
Eyes | 5 | Nystagmus, Ptosis, Slow saccadic eye movements |
Arms and legs | 2 | Impaired vibration sensation in the lower limbs, Generalized limb muscle atrophy |
Bones and joints | 1 | Skeletal muscle atrophy |
Lab test results | 1 | Increased circulating lactate concentration |
Ears | 1 | Hearing loss (hearing impairment) |
The clinical picture of LBSL consists of slowly progressive cerebellar ataxia, spasticity, and dorsal column dysfunction, involving the legs more than the arms. Most affected individuals have decreased position and vibration sense of the legs more than the arms, leading to increased difficulty walking in the dark. Manual dexterity becomes impaired to a variable degree. To date, more than 100 individuals have been identified with biallelic pathogenic variants in DARS2. Large series as well as multiple case reports [, , , , , ] have been described. Prospective natural history data are currently not available. The following description of the phenotypic features associated with this condition is based on the cited reports. Table 2. Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation: Frequency of Select Features
Feature | % of Persons w/Feature | Comment |
|---|---|---|
Normal early development | 80% | Infantile form was recently identified ; relative incidence is not clear yet but probably low. |
DARS2 encodes aspartyl-tRNA synthetase 2, mitochondrial (645 aa). Catalyzes the attachment of aspartate to tRNA(Asp) in a two-step reaction: aspartate is first activated by ATP to form Asp-AMP and then transferred to the acceptor end of tRNA(Asp) Highest expression in Cells EBV-transformed lymphocytes (44.3 TPM) and Cells Cultured fibroblasts (27.9 TPM).
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome is associated with mutations in the DARS2 gene on chromosome 1.
DARS2 is classified as a druggable target (Enzyme category) with score 0.0.
An overview study of 66 affected individuals revealed preliminary evidence in support of a genotype-phenotype correlation . A recent study on antenatal and early-infantile presentation of LBSL substantiates genotype-phenotype correlation. Individuals with this presentation lack the common "leaky" splice site variants and instead have more severe loss-of-function variants .
Source: GeneReviews — "Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation"
Diagnosis of leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL) should be suspected in individuals with characteristic abnormalities observed on brain and spinal cord MRI . However, atypical presentations with antenatal or early-infantile onset characterized by either profound cerebral atrophy or a leukoencephalopathy in the absence of typical involvement of tracts in the brain stem and spinal cord have been described; see *NOTE: (1) .
See , , , , and . Major criteria. EITHER:
Source: GeneReviews — "Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation"
Classic Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation The classic clinical picture of leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL) consists of slowly progressive cerebellar ataxia, spasticity, and dorsal column dysfunction, involving the legs more than the arms. The tendon reflexes are retained. Based on these findings alone, many disorders can be considered ; however, characteristic brain and spinal cord MRI findings distinguish LBSL from other disorders with overlapping clinical features. Ataxia. MRI findings distinguish LBSL from other hereditary ataxias .
Source: GeneReviews — "Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation"
Genetic testing for DARS2 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome. The disease remains an area of unmet medical need.
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL), the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 3. Recommended Evaluations Following Initial Diagnosis in Individuals with Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation
System/Concern | Evaluation | Comment |
|---|---|---|
Neurodevelopment | Neurologic exam | Consider:; Brain spinal cord MRI proton MRS of abnormal cerebral white matter;; EEG if seizures are suspected. PT/OT/rehab medicine assessment |
Genetic counseling | By genetics professionals1 | To obtain a pedigree inform affected persons families re nature, MOI, implications of LBSL to facilitate medical personal decision making Family support/ resources |
Manifestation/Concern | Treatment | Considerations/Other |
Spasticity | PT rehab medicine to improve motor function prevent contractures scoliosis | Assess need for positioning mobility devices, disability parking placard. |
Seizures | ASM if epileptic seizures are present |
Source: GeneReviews — "Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation"
Case reports have described neurologic deterioration following head trauma (as has been reported for several other leukodystrophies including vanishing white matter and adrenoleukodystrophy). The exact risk is not clear. No specific guidelines exist for contact sports or other activities. Affected individuals should be counseled on the above-mentioned observations and can then make an individual decision based on personal preference .
Source: GeneReviews — "Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation"
View trials for leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome
Table 5. Recommended Surveillance for Individuals with Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation
System/Concern | Evaluation | Frequency |
|---|---|---|
Neurologic | Assess for new manifestations (e.g., seizures, changes in tone, movement disorders). | At each visit Monitor those w/seizures. |
Development | Monitor developmental progress educational needs. | At each visit throughout childhood Miscellaneous/ |
Other | Assess family need for social work support (e.g., palliative/respite care, home nursing; other local resources) care coordination. | At each visit |
Source: GeneReviews — "Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation"
Phenotype severity distribution: 1 very common feature, 12 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome.
2 publications have been identified in PubMed for leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Huang WL (2025). [PMID: 40185339](https://pubmed.ncbi.nlm.nih.gov/40185339/). *Biochim Biophys Acta Mol Basis Dis*. [Basic Science / Preclinical]
Heckl S (2024). [PMID: 37169348](https://pubmed.ncbi.nlm.nih.gov/37169348/). *Rofo*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 7:09 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Loss of motor skills | 100% | Core feature of LBSL Cerebellar ataxia |
Axonal neuropathy | Uncommon | or absent tendon reflexes, distal weakness, sensory loss |
Learning disability | 20% | Most often learning disability; severe intellectual impairment is rare. |
Cognitive decline | 20% | — |
Epilepsy | Uncommon | Usually easily controlled w/ASM ASM = anti-seizure medication; Antenatal and early-infantile onset. Severe form characterized by microcephaly, severe developmental delay, epilepsy, and often early death; Childhood onset. Most common form with slow progression. |
Source: GeneReviews — "Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation"
— |
Dysarthria | Speech therapy | — |
Intellectual disability | Early intervention IEP as indicated | Family/Community |
System/Concern | Evaluation | Frequency |
Neurologic | Assess for new manifestations (e.g., seizures, changes in tone, movement disorders). | At each visit Monitor those w/seizures. |
Development | Monitor developmental progress educational needs. | At each visit throughout childhood Miscellaneous/ |
Other | Assess family need for social work support (e.g., palliative/respite care, home nursing; other local resources) care coordination. | At each visit Case reports have described neurologic deterioration following head trauma (as has been reported for several other leukodystrophies including vanishing white matter and adrenoleukodystrophy). The exact risk is not clear. |